OrbiMed Israel BioFund GP Limited Partnership → Eledon Pharmaceuticals, Inc. ELDN

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 4.21

7,193,953 shares short · -14.5% vs prior

Other 13D/G Filings on Eledon Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2018-05-15	SC	APPLE TREE PARTNERS II LP	—	—	view →
2018-05-02	SC	APPLE TREE PARTNERS II LP	—	—	view →
2018-04-17	SC	Novartis Bioventures Ltd	—	—	view →
2018-03-19	SC	OrbiMed Israel BioFund GP Limited Partnership	—	—	view →
2018-01-08	SC	APPLE TREE PARTNERS II LP	—	—	view →

Other Filings by OrbiMed Israel BioFund GP Limited Partnership

Filed	Form	Issuer	Stake	Shares
2022-07-01	SC	9 METERS BIOPHARMA, INC.	—	—	view →
2021-04-07	SC	9 METERS BIOPHARMA, INC.	—	—	view →
2018-03-19	SC	Novus Therapeutics, Inc. ELDN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →